-
ANXIETY AND DEPRESSIVE SYMPTOM BURDEN AND ITS ASSOCIATION WITH FUNCTIONAL IMPAIRMENT IN PULMONARY FIBROSIS IN GREECE
Aug 11, 2026, 17:16 PM -
DIFFERENT LEVERS, SAME DIRECTION: HOW THREE EUROPEAN HTA ARCHETYPES TRANSLATE UNMET NEED INTO ADDED-VALUE VERDICTS FOR GENE THERAPIES
Aug 11, 2026, 17:16 PM -
CLOSING THE LANGUAGE GAP IN HEOR REVIEWS: VALIDATING AI-ASSISTED SCREENING OF CHINESE-LANGUAGE EVIDENCE
Aug 11, 2026, 17:16 PM -
TREATMENT PREFERENCES FOR PHARMACOLOGICAL THERAPIES IN ALZHEIMER'S DISEASE: A SCOPING REVIEW OF STATED-PREFERENCE STUDIES
Aug 11, 2026, 17:16 PM -
ASSESSING THE AVOIDABLE HEALTHCARE COSTS OF OFF-LABEL QUETIAPINE IN DEMENTIA: A RETROSPECTIVE ANALYSIS OF MIS-CHANNELLING DISPENTIONS
Aug 11, 2026, 17:16 PM -
INTEGRATING EQUITY INTO HTA VALUE ASSESSMENT IN EUROPE: A TARGETED LITERATURE REVIEW OF FRAMEWORKS, METHODS, AND POLICY APPLICATIONS ACROSS MAJOR HTA AGENCIES
Aug 11, 2026, 17:16 PM -
CLINICAL VALUE OF OLEZARSEN IN PREVENTING THE FIRST ACUTE PANCREATITIS EVENT IN SEVERE HYPERTRIGLYCERIDEMIA: A UK MODELING STUDY
Aug 11, 2026, 17:16 PM -
UNDERSTANDING HOW CLINICAL UNCERTAINTY IS SCRUTINISED ACROSS EUROPEAN HTA APPRAISALS OF GENE THERAPIES, AND IMPLICATIONS FOR COMMERCIALISATION IN THE JOINT CLINICAL ASSESSMENT ERA
Aug 11, 2026, 17:16 PM -
AGENTIC AI FOR DATASET QUALITY ASSURANCE AND LATENT CLASS ANALYSIS: A HUMAN-IN-THE-LOOP METHODOLOGICAL FRAMEWORK APPLIED TO THE SWAN COHORT
Aug 11, 2026, 17:16 PM -
L1-DISTANCE-BASED SIMILARITY FRAMEWORK FOR CLUSTERING IRREGULAR LONGITUDINAL DATA
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF ANTI-OBESITY TREATMENTS; A TLR ON MODELING APPROACHES
Aug 11, 2026, 17:16 PM -
QUANTIFYING THE FUTURE HEALTH, ECONOMIC, SOCIETAL, AND ENVIRONMENTAL IMPACT OF OPTIMISED GUIDELINE-DIRECTED MEDICAL THERAPY ON POTENTIALLY AVOIDABLE HOSPITALISATIONS ACROSS MULTIPLE COUNTRIES: THE GLOBALPAH PROGRAM
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF CONTINUOUS GLUCOSE MONITORING IN TYPE 2 DIABETES MELLITUS: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
UNDERSTANDING HOW TO MEASURE WHOLE HEALTH: AN EXPLORATIVE STUDY TO IDENTIFY WHOLE HEALTH TOOLS FOR OUTCOMES RESEARCH
Aug 11, 2026, 17:16 PM -
IMPLICATIONS OF A NEWLY INTRODUCED RARITY-BASED PRICING FRAMEWORK IN SWEDEN: A REVIEW OF ORPHAN MEDICINE REIMBURSEMENT DECISIONS IN SCANDINAVIA
Aug 11, 2026, 17:16 PM -
FINANCIAL AND ACCESS BARRIERS FROM CLINICAL NOTES USING HUMAN-IN-THE-LOOP LLM: EVIDENCE FROM A PCSK9 INHIBITOR-TREATED COHORT USING NORSTELLALINQ
Aug 11, 2026, 17:16 PM -
NICE OBESITY REFERENCE CASE EXTENSION SETTING STANDARDISED METHODS FOR ECONOMIC EVALUATION
Aug 11, 2026, 17:16 PM -
BURDEN OF SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) EXACERBATIONS IN ENGLAND: THE COPD SEVERE EXACERBATIONS (COVERS) REAL-WORLD EVIDENCE STUDY
Aug 11, 2026, 17:16 PM -
APPLYING NETNOGRAPHY TO INFORM DISCRETE CHOICE EXPERIMENT ATTRIBUTE DEVELOPMENT: AN EVALUATION OF GLP-1 RECEPTOR AGONISTS FOR OBESITY
Aug 11, 2026, 17:16 PM -
COMPARATIVE ANALYSIS OF BIOSIMILARS PROCUREMENT SYSTEMS IN THE INPATIENT SECTOR IN POLAND AND NORWAY. COST OPTIMISATION AND PATIENT ACCESS (SELECTED ANTI-TNF MEDICINES)
Aug 11, 2026, 17:16 PM
